CYP3A5 and NAT2 gene polymorphisms: role in childhood acute lymphoblastic leukemia risk and treatment outcome (2012)
- Authors:
- USP affiliated authors: TONE, LUIZ GONZAGA - FMRP ; QUEIROZ, ROSANE GOMES DE PAULA - FMRP ; SCRIDELI, CARLOS ALBERTO - FMRP
- Unidade: FMRP
- DOI: 10.1007/s11010-011-1220-8
- Subjects: POLIMORFISMO; RISCO; LEUCEMIA; INFÂNCIA
- Language: Inglês
- Imprenta:
- Source:
- Título: Molecular and Cellular Biochemistry
- ISSN: 0300-8177
- Volume/Número/Paginação/Ano: online, 2012
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
SILVEIRA, Vanessa S. et al. CYP3A5 and NAT2 gene polymorphisms: role in childhood acute lymphoblastic leukemia risk and treatment outcome. Molecular and Cellular Biochemistry, 2012Tradução . . Disponível em: https://doi.org/10.1007/s11010-011-1220-8. Acesso em: 10 jan. 2026. -
APA
Silveira, V. S., Canalle, R., Scrideli, C. A., Queiroz, R. G. de P., Lopes, L. F., & Tone, L. G. (2012). CYP3A5 and NAT2 gene polymorphisms: role in childhood acute lymphoblastic leukemia risk and treatment outcome. Molecular and Cellular Biochemistry. doi:10.1007/s11010-011-1220-8 -
NLM
Silveira VS, Canalle R, Scrideli CA, Queiroz RG de P, Lopes LF, Tone LG. CYP3A5 and NAT2 gene polymorphisms: role in childhood acute lymphoblastic leukemia risk and treatment outcome [Internet]. Molecular and Cellular Biochemistry. 2012 ;[citado 2026 jan. 10 ] Available from: https://doi.org/10.1007/s11010-011-1220-8 -
Vancouver
Silveira VS, Canalle R, Scrideli CA, Queiroz RG de P, Lopes LF, Tone LG. CYP3A5 and NAT2 gene polymorphisms: role in childhood acute lymphoblastic leukemia risk and treatment outcome [Internet]. Molecular and Cellular Biochemistry. 2012 ;[citado 2026 jan. 10 ] Available from: https://doi.org/10.1007/s11010-011-1220-8 - Inibidor de histona desacetilase LBH589 promove efeitos antineoplásicos em leucemia linfoide aguda
- Low mRNA expression of the apoptosis-related genes CASP3, CASP8, and FAS is associated with low induction treatment response in childhood acute lymphoblastic leukemia (ALL)
- Anti-CD20 monoclonal antibody therapy and minimal residual disease status of T-cell/histiocyte-rich large B cell non-hodgkin lymphoma. [Carta ao Editor]
- Protein expression of matrix metalloproteinase (MMP-1, -2, -3, -9 and -14) in Ewing family tumors and medulloblastomas of pediatric patients
- Can zebularine be an altenative drug to tomozolomide resistant glioblastoma ?
- Effects of zebularine in childhood acute lymphoblastic Leukemia cells
- Zebularina promove diminuição da proliferação celular, apoptose e radiosensibilização em glioblastoma
- Aurora kinase inhibition as a potential new therapeutic strategy in childhood adrenocortical tumor
- Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes in a brasilian population
- Expression profile of a apoptosis-related genes by real-time quantitative PCR in children with acute lymphoblastic leukemia
Informações sobre o DOI: 10.1007/s11010-011-1220-8 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
